The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal award activity of ChangePoint Integrated Health under programs of the federal government for the year ended September 30, 2023. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of ChangePoint Integrated Health, it is not intended to and does not present the financial position, changes in net assets, or cash flows of ChangePoint Integrated Health. ChangePoint Integrated Health did not provide federal awards to subrecipients during the year ended September 30, 2023.
In the event that the grantor was either unable to or did not confirm the source of federal funds all amounts were assumed to be federal for purposes of the schedule of expenditures of federal awards.
Major programs are identified in the Summary of Auditor's Results section of the Schedule of Findings and Questioned Costs.
The mortgage balances, under CFDA No. 14.239 at the beginning of the year totaling $870,236 is included in the federal expenditures presented in the Schedule. There were no new loans during the year which would require presentation in the Schedule. The outstanding balance of the federally insured mortgages at June 30, 2025 also totaled $870,236.
The following reconciliation of the revenue recognized in the accompanying Schedule of Expenditures of Federal Awards to the government awards recognized in the audited financial statements: Total Federal Expenditures from SEFA $1,196,254, Less loan balances included in federal expenditures of $870,236, Plus nonfederal government grants and contracts of $1,441,703 = $1,767,721 (Statement of Operations - Other grants and related revenue)
In accordance with OMB Uniform Guidance, Type A programs are all programs with expenditures equal to or greater than $750,000 and Type B programs are all programs with expenditures less than $750,000. Major programs were determined using a risk-based approach. There were no identified program clusters for the year ended September 30, 2023.